Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons
New England Journal of Medicine · 03.04.2025 · 392 (13) · 1261-1276
DOI: 10.1056/nejmoa2411858 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 03.04.2025. Verfasst von Colleen F Kelley und 55 weiteren Autor:innen. Beteiligte Einrichtung: Hope Clinic of Emory University School of Medicine, Decatur, GA. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections, Pre-Exposure Prophylaxis. Die Arbeit wurde bisher 313-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: NIAID NIH HHS, Gilead Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hope Clinic of Emory University School of Medicine, Decatur, GA.
- Grady Health System, Atlanta.
- Centro Ararat, San Juan, Puerto Rico.
- Divisions of Pediatric and Adult Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore.
- HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre and Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Be Well Medical Center, Berkley, MI.
ORCID-Profile: Colleen F Kelley, Jesse Clark, Aditya Gaur
Förderung
- NIAID NIH HHS
- Gilead Sciences
Zitieren
APA
Kelley, C. F., Acevedo-Quiñones, M., Agwu, A. L., Avihingsanon, A., Benson, P., Blumenthal, J., Brinson, C., Brites, C., Cahn, P., Cantos, V. D., Clark, J., Clement, M., Creticos, C., Crofoot, G., Diaz, R. S., Doblecki-Lewis, S., Gallardo-Cartagena, J. A., Gaur, A., Grinsztejn, B., …, & PURPOSE 2 Study Team (2025). Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. New England Journal of Medicine, 392(13), 1261-1276. https://doi.org/10.1056/nejmoa2411858
Vancouver
Kelley CF, Acevedo-Quiñones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, et al. Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. New England Journal of Medicine. 2025;392(13):1261-1276. doi:10.1056/nejmoa2411858
BibTeX
@article{Kelley2025,
author = {Kelley, Colleen F and Acevedo-Quiñones, Maribel and Agwu, Allison L and Avihingsanon, Anchalee and Benson, Paul and Blumenthal, Jill and Brinson, Cynthia and Brites, Carlos and Cahn, Pedro and Cantos, Valeria D and Clark, Jesse and Clement, Meredith and Creticos, Cathy and Crofoot, Gordon and Diaz, Ricardo S and Doblecki-Lewis, Susanne and Gallardo-Cartagena, Jorge A and Gaur, Aditya and Grinsztejn, Beatriz and Hassler, Shawn and Hinojosa, Juan Carlos and Hodge, Theo and Kaplan, Richard and Lacerda, Marcus and LaMarca, Anthony and Losso, Marcelo H and Valdez Madruga, José and Mayer, Kenneth H and Mills, Anthony and Mounzer, Karam and Ndlovu, Nkosiphile and Novak, Richard M and Perez Rios, Alma and Phanuphak, Nittaya and Ramgopal, Moti and Ruane, Peter J and Sánchez, Jorge and Santos, Breno and Schine, Patric and Schreibman, Tanya and Spencer, LaShonda Y and Van Gerwen, Olivia T and Vasconcelos, Ricardo and Vasquez, Jose Gabriel and Zwane, Zwelethu and Cox, Stephanie and Deaton, Chris and Ebrahimi, Ramin and Wong, Pamela and Singh, Renu and Brown, Lillian B and Carter, Christoph C and Das, Moupali and Baeten, Jared M and Ogbuagu, Onyema and PURPOSE 2 Study Team, PURPOSE 2 Study Team},
title = {Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {13},
pages = {1261--1276},
doi = {10.1056/nejmoa2411858}
}
EUVIMED